Literature DB >> 3711337

Identification and characterization of specific binding proteins for growth hormone in normal human sera.

A C Herington, S Ymer, J Stevenson.   

Abstract

The well-recognized "big" forms (45,000-100,000 mol wt) of immunoreactive human growth hormone (hGH) in human serum have been reported to be random aggregates or formal polymers. However, we have now investigated the possibility that they are protein-bound forms. After incubation of monomeric 125I-hGH with normal serum, gel chromatography indicated a peak of bound 125I-hGH (at approximately 120,000 mol wt), which was completely displaced by excess unlabeled hGH. When serum alone was chromatographed two peaks of specific binding were subsequently detected, the major peak, eluting between 74,000 and 85,000 mol wt corresponded to the 125I-hGH-binding protein complex observed at approximately 120,000 mol wt. Using a mini-gel filtration system for separating bound from free hormone, binding of 125I-hGH by normal human serum was dependent on time (equilibrium was reached in 2 h at 21 degrees C), temperature (21 degrees C greater than 37 degrees C), Ca2+ and serum concentrations. Binding was reversible and highly specific for hGH, not being displayed by GH or prolactins from several species. Scatchard analysis revealed linear plots with an affinity (KA) of 0.32 +/- 0.06 X 10(9) M-1 (n = 7). Human serum with low endogenous hGH levels, when added to rabbit liver membranes, decreased the binding of 125I-hGH in this tissue in a dose-dependent manner. These data indicate that human sera contain a specific, high affinity binding protein for hGH and that this may account, at least in part, for the known size heterogeneity of GH in serum. Its effect on GH binding to target tissues may indicate a role for the binding protein in the regulation of GH action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711337      PMCID: PMC370539          DOI: 10.1172/JCI112507

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  PROTEIN BOUND HUMAN GROWTH HORMONE.

Authors:  P J COLLIPP; S A KAPLAN; D C BOYLE; C S SHIMIZU
Journal:  Metabolism       Date:  1964-06       Impact factor: 8.694

2.  Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay.

Authors:  M A Lesniak; P Gorden; J Roth; J R Gavin
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

3.  Interaction of 14C-labeled human and bovine growth hormone with serum proteins.

Authors:  P J Collipp; S A Kaplan
Journal:  Biochim Biophys Acta       Date:  1966-04-25

4.  Modified forms of human growth hormone with increased biological activities.

Authors:  R N Singh; B K Seavey; V P Rice; T T Lindsey; U J Lewis
Journal:  Endocrinology       Date:  1974-03       Impact factor: 4.736

5.  Isohormones of human growth hormone. II. Plasmin-catalyzed transformation and increase in prolactin biological activity.

Authors:  R A Yadley; A Chrambach
Journal:  Endocrinology       Date:  1973-10       Impact factor: 4.736

6.  Existence of two forms of immunoreactive growth hormone in human plasma.

Authors:  A D Goodman; R Tanenbaum; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

7.  Evidence for "big" and "little" components of human plasma and pituitary growth hormone.

Authors:  P Gorden; C M Hendricks; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

8.  Plasma biological and immunoreactive human growth hormone-like activity.

Authors:  R M Bala; K A Ferguson; J C Beck
Journal:  Endocrinology       Date:  1970-09       Impact factor: 4.736

9.  Heterogeneity of circulating growth hormone in acromegaly.

Authors:  R C Dimond; L Wartofsky; S W Rosen
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

10.  Studies on "big" growth hormone from human plasma and pituitary.

Authors:  D R Wright; A D Goodman; K D Trimble
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

View more
  21 in total

Review 1.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

2.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 3.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

4.  Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.

Authors:  L M Winer; M A Shaw; G Baumann
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

5.  Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.

Authors:  N Dávila; M Moreira-Andrés; J Alcañiz; B Barceló
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

6.  Pharmacokinetics of radioiodinated human and ovine growth hormones in transgenic mice expressing bovine growth hormone.

Authors:  D Turyn; A Bartke
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

7.  Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

Authors:  W H Daughaday; B Trivedi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

Authors:  J Mordenti; S A Chen; J A Moore; B L Ferraiolo; J D Green
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

10.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.